Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Biomarker-guided stratified individualized treatment study in psoriasis
ChiCTR2000036192Phase 4Recruiting
- Sponsor
- Huashan Hospital
- Start
- Aug 2020
- Modality
- Orthosteric Ligands → Classical Binding Small Molecules → Small Molecules, Metabolically Activated Prodrugs → Prodrugs/Conditional Activator Small Molecules → Small Molecules, Nucleic Acid-Directed Small Molecules → Small Molecules
- Countries
- 1
01
Overview
Phase 4, open-label trial of methotrexate in psoriasis (3 arms), sponsored by Huashan Hospital. Primary endpoint: PASI75 response rate. Started Aug 2020; status: recruiting.
02
Drugs
methotrexate
03
Conditions
psoriasis
Beyond the preview
Go deeper on ChiCTR2000036192.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ChiCTR2000036192.